BNGO — Bionano Genomics, Inc.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1411690 ·
Last close
$0.95
Market Cap
$13.32M
52W High
$2.23
52W Low
$0.93
ADV30
241,785
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 8,276,000 | 3,949,000 | -6,536,000 | -6,453,000 | 46,291,000 | 4,355,000 | 18,081,000 |
| Jun 2026 | 8,171,000 | 4,314,000 | -7,218,000 | -7,423,000 | 47,591,000 | 3,730,000 | 15,985,000 |
| Mar 2026 | 6,687,000 | 3,252,000 | -7,897,000 | -8,303,000 | 64,804,000 | 3,425,000 | 27,341,000 |
| Dec 2025 | 7,951,000 | 3,399,000 | -8,536,000 | -7,933,000 | 73,584,000 | 2,990,000 | 29,160,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,480,000
Investing CF
$18,478,000
Financing CF
$2,643,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.01
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-735,346,000
Inventory
$5,202,000
Receivables
$4,366,000
ST Investments
$6,189,000
EBIT TTM
$-31,267,000
Pretax Income TTM
$-32,096,000
Interest Exp TTM
$829,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$31,085,000
EBITDA
$-20,752,000
Free Cash Flow
$4,355,875
Enterprise Value
$12,364,000
Total Cash
$8,168,000
Total Debt
$6,543,000
Shares Out
13,989,000
Trailing EPS
$-2.90
Book Value
$2.09
ROE
-77.2%
ROA
-30.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 28,508,000 | -33,339,000 | -26,395,000 | 73,584,000 | 29,160,000 | 44,424,000 | -16,345,000 |
| Dec 2024 | 30,776,000 | -76,278,000 | -112,017,000 | 76,670,000 | 41,295,000 | 35,375,000 | -68,922,000 |
| Dec 2023 | 36,116,000 | -137,224,000 | -232,493,000 | 214,404,000 | 118,247,000 | 96,157,000 | -125,181,000 |
| Dec 2022 | 27,802,000 | -131,698,000 | -132,596,000 | 307,502,000 | 58,104,000 | 249,398,000 | -124,816,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$30,176,000
NetIncome TTM
$-32,162,000
OpCashFlow TTM
—
Assets (Latest)
$47,591,000
Forward EPS
$-0.97
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TRGXF | Terra Rossa Gold Ltd. | $13.40M | $0.18 | — |
| CLIR | ClearSign Technologies Corp | $13.48M | $1.98 | — |
| PLCKF | Plurilock Security Inc. | $13.48M | $0.12 | — |
| COGDF | Compass Gold Corp | $13.11M | $0.09 | — |
| GRLMF | GreenLight Metals Inc. | $13.54M | $0.14 | — |
News headlines (Yahoo Finance, 1h cache)
Bionano Genomics Inc (BNGO) (Q3 2026) Earnings Call Highlights: Record Flow Cell Sales and ...
2026-11-11 17:04 · Yahoo
Bionano Genomics (BNGO) Q3 2026 Earnings Call Transcript
2026-11-11 04:33 · Yahoo
Bionano Genomics, Inc. Q3 2026 Earnings Call Summary
2026-11-11 02:06 · Yahoo
Bionano Reports Third Quarter 2026 Results and Provides a Business Update
2026-11-10 21:05 · Yahoo
Bionano to Report Third Quarter 2026 Financial Results and Host a Conference Call Webcast on November 10, 2026
2026-10-27 20:05 · Yahoo
Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
2026-09-23 13:00 · Yahoo
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms
2026-09-10 13:00 · Yahoo
Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping
2026-09-08 13:00 · Yahoo
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-24 12:00 · Yahoo
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript
2026-08-17 21:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.